Polyclonal Antibody Market, By Type, By Source, By Application, By End User,, By Region

Description

The global polyclonal antibody market size is expected to reach US$ 1,638.7 Mn by 2030, from US$ 1,096.9 Mn in 2023, exhibiting compound annual growth rate (CAGR) of 5.9% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 1,096.9 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.90%	2030 Value Projection:	US$ 1,638.7 Mn

Figure 1. Global Polyclonal Antibody Market Share (%), By Region, 2023

Polyclonal antibodies are immunoglobulin that bind nonspecifically to multiple epitopes of an antigen. They are commonly produced by injecting the antigen into an animal and harvesting the resulting serum containing the immunoglobulin. Factors such as the rising prevalence of various chronic and infectious diseases, increasing research and development investments in the pharmaceutical and biotechnology sectors, and the growing adoption of polyclonal antibodies for research applications are expected to drive the growth of this market. However, stringent regulatory guidelines for product approval may impede market growth to some extent. Polyclonal antibodies are a heterogeneous mix of antibodies derived from the immune response of multiple B-cells, in which each one recognizes a different epitope on the same antigen. Polyclonal antibodies are composed of a mixture of antibodies that represent the natural immune response to an antigen. Polyclonal antibodies are used in general research applications

Market Dynamics:

The global polyclonal antibody market is projected to grow at a steady pace during the forecast period owing to various driving factors such as rising prevalence of chronic and infectious diseases, and growing adoption in various research applications. Furthermore, ongoing innovations in diagnostic technology and a rapid shift towards polyclonal antibodies as an inexpensive alternative to monoclonal antibodies are expected to boost demand. However, the high costs associated with the purification and heterogeneity of polyclonal antibodies along with stringent regulatory approvals, pose major challenges to the market. On the other hand, development of advanced purification techniques, labeling processes, and recombinant antibody production creates growth opportunities during the forecast period

Key features of the study:

This report provides an in-depth analysis of the global polyclonal antibody market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global polyclonal antibody market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Santa Cruz Biotechnology, Inc., GenScript, Merck KGaA, Bio-Rad Laboratories, Inc., BioLegend, Inc., GeneTex, ROCKLAND IMMUNOCHEMICALS, INC., Abcam plc., Creative Diagnostics, Crown Bioscience, Takara Bio Inc., Geno Technology Inc., IGY Immune Technologies and Life Sciences Inc., EpigenTek Group Inc., Takeda Pharmaceutical Company Limited and SAB Biotherapeutics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global polyclonal antibody market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing global polyclonal antibody market

Detailed Segmentation:

Global Polyclonal Antibody Market, Type:
- Primary Antibody
- Secondary Antibody
Global Polyclonal Antibody Market, Source:
- Rabbits
- Goats
- Sheep
- Others
Global Polyclonal Antibody Market, By Application:
- Academic Research
- Diagnostics
- Others
Global Polyclonal Antibody Market, By End User:
- Academic & Research Institutes
- Pharmaceutical and Biotechnology Companies
- Others
Global Polyclonal Antibody Market , By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles
- Thermo Fisher Scientific Inc.
- Santa Cruz Biotechnology, Inc.
- GenScript
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- BioLegend, Inc.
- GeneTex
- ROCKLAND IMMUNOCHEMICALS, INC.
- Abcam plc.
- Creative Diagnostics
- Crown Bioscience
- Takara Bio Inc.
- Geno Technology Inc.
- IGY Immune Technologies and Life Sciences Inc.
- EpigenTek Group Inc.
- Takeda Pharmaceutical Company Limited
- SAB Biotherapeutics

Product Code: CMI4347

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Type
- Market Snippet, By Source
- Market Snapshot, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

Market Dynamics
- Drivers
Increasing product launch
Partnerships among key market players
- Restraints
The high costs associated with polyclonal antibody production
Stringent regulations
- Market Opportunities
Growing applications of polyclonal antibodies in diagnostics
Adoption of recombinant polyclonal antibodies
Impact Analysis
Regulatory Guidelines
Product launches
Key Development
PEST Analysis
PORTER's Analysis
Regulatory Scenario
Mergers and Acquisitions
Manufacturer Revenue
Healthcare Spending by Country

4. Global Polyclonal Antibody Market - COVID-19 Impact Analysis

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Polyclonal Antibody Market, By Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Primary Antibody
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Secondary Antibody
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Global Polyclonal Antibody Market, By Source, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Rabbits
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Goats
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Sheep
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Others (Rats, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Global Polyclonal Antibody Market, By Application, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Academic Research
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

8. Global Polyclonal Antibody Market, By End User, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Pharmaceutical and Biotechnology Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Others (Diagnostic Centers, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

9. Global Polyclonal Antibody Market , By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country, 2019-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Platform, 2018- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018- 2030, (US$ Mn)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Santa Cruz Biotechnology, Inc.
GenScript
Merck KGaA
Bio-Rad Laboratories, Inc.
BioLegend, Inc.
GeneTex
ROCKLAND IMMUNOCHEMICALS, INC.
Abcam plc.
Creative Diagnostics
Crown Bioscience
Takara Bio Inc.
Geno Technology Inc.
IGY Immune Technologies and Life Sciences Inc.
EpigenTek Group Inc.
Takeda Pharmaceutical Company Limited
SAB Biotherapeutics

11. Section

Research Methodology
About Us